KaydedilenlerDerginizi ekleyin

Dergiler / Gülhane Tıp Dergisi / 2018 / Cilt: 60 - Sayı: 1

Pathology results, complications of prostate biopsies and correlation with radical prostatectomy: Analysis of 1509 patients

Selçuk SARIKAYA
Murat YILDIRIM
Erman DAMAR
Çağrı ŞENOCAK
ÖMER FARUK BOZKURT
Sayfa
19–25
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusions: Despite the importance of TRUS-guided prostate biopsy in diagnosis of PCa, the present study showed inaccuracy when compared to the result of the radical prostatectomy

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: Prostate cancer is a global health problem and the second most common cancer in men.
📊
Temel Bulgular & Veri:Methods: 1509 patients who underwent TRUS-guided prostate biopsy in Kecioren Training and Research Hospital between January 2008 and January 2017 were included in the study.
💡
Sonuç & Katkı:Conclusions: Despite the importance of TRUS-guided prostate biopsy in diagnosis of PCa, the present study showed inaccuracy when compared to the result of the radical prostatectomy
🔬Tür:Araştırma Makalesi
📍Kapsam:2008 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Aims: Prostate cancer is a global health problem and the second most common cancer in men. In this study, we aimed to analyse the pathologic results, complications of prostate biopsies and the comparison of histopathologic results with the results of radical prostatectomy. Methods: 1509 patients who underwent TRUS-guided prostate biopsy in Kecioren Training and Research Hospital between January 2008 and January 2017 were included in the study. Results: 1116 patients were diagnosed as BPH and 393 patients were as PCa. Average PSA level was 9,27ng/ml for BPH group. 52 patients had urinary tract infections after prostate biopsy for BPH group and one had severe hemorrhage. The average age of PCa group was 67,3 years. Average PSA level was 29,87ng/ml. Conclusions: Despite the importance of TRUS-guided prostate biopsy in diagnosis of PCa, the present study showed inaccuracy when compared to the result of the radical prostatectomy

🔖

Bu Makaleye Atıf Yap

SARIKAYA, S., YILDIRIM, M., DAMAR, E., ŞENOCAK, Ç., BOZKURT, Ö. F. (2018). Pathology results, complications of prostate biopsies and correlation with radical prostatectomy: Analysis of 1509 patients. Gülhane Tıp Dergisi, Cilt: 60 - Sayı: 1, 19–25. https://ajindex.com/articles/165015

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Jia Y, Zhu LY, Xian YX, et al. Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases. World J Surg Oncol. 2017;15(1):165. Koc G, Turk H, Karabicak M, Un S, Ergani B, Ekin RG. Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/ mL? Curr Ther Res Clin Exp. 2017;84:50-53.
  2. Seo HK, Chung MK, Ryu SB, Lee KH. Korean Urological Oncologic Society Prostate Cancer Study G. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study. Urology. 2007;70(6):1109- 1112. Guo G, Xu Y, Zhang X. TRUS-guided transperineal prostate 12+X core biopsy with template for the diagnosis of prostate cancer. Oncol Lett. 2017;13(6):4863- 4867. Mohamed ZK, Dominguez-Escrig J, Vasdev N, Bharathan B, Greene D. The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level Lee A, Lim J, Gao X, Liu L, Chia SJ. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore. Asia Pac J Clin Oncol. 2017;13(5):348-355.
  3. Makarov DV, Trock BJ, Humphreys EB, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology. 2007;69(6):1095-1101.
  4. Bulbul MA, El-Hout Y, Haddad M, et al. Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer. Can Urol Assoc J. 2007;1(3):264-266.
  5. Simsir A, Kismali E, Mammadov R, Gunaydin G, Cal C. Is it possible to predict sepsis, the most serious complication in prostate biopsy? Urol Int. 2010;84(4):395-399.
  6. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630. Men. J Urol. 2017;197(2): 200-207.
  7. Agnihotri S, Mittal RD, Kapoor R, Mandhani A. Raising cut-off value of prostate specific antigen (PSA) for biopsy in symptomatic men in India to reduce unnecessary biopsy. Indian J Med Res. 2014;139(6):851-856.
  8. Pepe P, Panella P, D'Arrigo L, Savoca F, Pennisi M, Aragona F. Should men with serum prostate-specif